Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Normal Adults”

4,263 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 4,263 results

Testing effectiveness (Phase 2)Study completedNCT00040846
What this trial is testing

Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+97 more
Fred Hutchinson Cancer Center 60
Early research (Phase 1)Ended earlyNCT05231668
What this trial is testing

Single Ascending Dose Study of SAR439459 in Adults With Osteogenesis Imperfecta (OI)

Who this might be right for
Osteogenesis Imperfecta
Sanofi 16
Large-scale testing (Phase 3)Study completedNCT00096603
What this trial is testing

Evaluate the Safety of Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2600g

Who this might be right for
Psoriasis
Genentech, Inc. 450
Early research (Phase 1)Ended earlyNCT06544642
What this trial is testing

Evaluate the Effects of ASP5502 in Healthy Adults and Adults With Primary Sjögren's Syndrome

Who this might be right for
Healthy VolunteersSjögren's Syndrome
Astellas Pharma Global Development, Inc. 116
Testing effectiveness (Phase 2)Active Not RecruitingNCT04711824
What this trial is testing

Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases

Who this might be right for
Breast CancerBrain Metastases, Adult
Colette Shen 41
Not applicableNot Yet RecruitingNCT07292896
What this trial is testing

Study on the Normal Reference Range and Clinical Significance of the Right Atrioventricular Coupling Index Assessed by Artificial Intelligence-Based Three-Dimensional Echocardiography

Who this might be right for
Healthy AdultsPulmonary HypertensionTricuspid Regurgitation+2 more
First Hospital of China Medical University 2,640
Early research (Phase 1)Study completedNCT00112476
What this trial is testing

Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors

Who this might be right for
Recurrent MelanomaRecurrent Renal Cell CancerStage IV Melanoma+2 more
National Cancer Institute (NCI) 24
Not applicableEnrolling By InvitationNCT04202094
What this trial is testing

Fertility in Young Adults Who Did (Not) Store Testicular Tissue Before a Treatment Leading to Fertility Problems

Who this might be right for
Childhood CancerHematological Disorders
Universitair Ziekenhuis Brussel 50
Not applicableNo Longer AvailableNCT04825613
What this trial is testing

"Individual Patient Expanded Access IND to Treat Primary Lateral Sclerosis"

Who this might be right for
Primary Lateral Sclerosis, Adult, 1
Hope Biosciences Research Foundation
Early research (Phase 1)Study completedNCT02780388
What this trial is testing

A Phase 1b Study of MEDI4920 in Participants With Adult-onset Rheumatoid Arthritis

Who this might be right for
Adult Onset Rheumatoid Arthritis
Amgen 57
Very early researchActive Not RecruitingNCT04634227
What this trial is testing

Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot)

Who this might be right for
SarcomaSoft Tissue SarcomaUnresectable Soft Tissue Sarcoma+2 more
University of Iowa 30
Testing effectiveness (Phase 2)Study completedNCT03131570
What this trial is testing

Safety and Efficacy of Secukinumab in Mild Psoriasis

Who this might be right for
Psoriasis
James G. Krueger, MD, PhD 23
Early research (Phase 1)Ended earlyNCT04751383
What this trial is testing

Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma

Who this might be right for
High Risk NeuroblastomaRecurrent NeuroblastomaRecurrent Osteosarcoma+2 more
National Cancer Institute (NCI) 12
Large-scale testing (Phase 3)Study completedNCT05369403
What this trial is testing

Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 86
Not applicableAvailableNCT05170724
What this trial is testing

Global Managed Access Program Cohort for Remibrutinib in Adult Patients With Chronic Spontaneous Urticaria

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals
Early research (Phase 1)Looking for participantsNCT07297979
What this trial is testing

Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)

Who this might be right for
Ewing Sarcoma
Amgen 50
Testing effectiveness (Phase 2)Study completedNCT03025542
What this trial is testing

Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of Bimekizumab in Patients With Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
UCB Biopharma SRL 49
Testing effectiveness (Phase 2)Study completedNCT00014573
What this trial is testing

Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer

Who this might be right for
Brain and Central Nervous System Tumors
Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)Ended earlyNCT00436436
What this trial is testing

O(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma Multiforme That Did Not Respond to Previous Temozolomide and Radiation Therapy

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI) 12
Early research (Phase 1)Study completedNCT02291471
What this trial is testing

Tolerance and Pharmacokinetics of T0001 in Healthy Adult Chinese Volunteers

Who this might be right for
Rheumatic Diseases
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. 56
Next Page